Log in

Relevant bibliographies by topics / Paradoxical Psoriasis / Journal articles

To see the other types of publications on this topic, follow the link: Paradoxical Psoriasis.

Journal articles on the topic 'Paradoxical Psoriasis'

Author: Grafiati

Published: 11 March 2023

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Paradoxical Psoriasis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Alaou, Rhita, Sofia Alami, Nawal Lagdali, et al. "Paradoxical cutaneous manifestations induced by TNF inhibitors in patients with inflammatory bowel disease." Our Dermatology Online 14, no. 1 (2023): 60–64. http://dx.doi.org/10.7241/ourd.20231.12.

Full text

Abstract:

Background: Anti-TNF drugs have revolutionized the management of numerous inflammatory diseases, yet they may produce paradoxical effects. Materials and Methods: A descriptive study was conducted on patients with chronic inflammatory bowel disease (IBD) on anti-TNF therapy who had developed paradoxical psoriasis. Results: Out of a total of 218 patients followed for IBD on TNF inhibitors, five presented with paradoxical psoriasis. In four patients, a specific treatment for psoriasis was associated with anti-TNF treatment. In one patient, a swap to ustekinumab was decided. Good progress was note

APA, Harvard, Vancouver, ISO, and other styles

2

ZEKEY, Emre, Pinar KARABAGLİ, and Gülcan SAYLAM KURTİPEK. "Adalimumab induced severe paradoxical psoriasis in a patient with ankylosing spondylitis." Cukurova Medical Journal 47, no. 4 (2022): 1768–70. http://dx.doi.org/10.17826/cumj.1170774.

Full text

Abstract:

Anti-tumor necrosis factor (Anti-TNF)’s have been used frequently in rheumatology and dermatology. These drugs may couse psoriasiform lesions paradoxically. In this report, ankylosing spondylitis patient who developed severe paradoxical psoriasis while being treated with adalimumab was discussed.

APA, Harvard, Vancouver, ISO, and other styles

3

Giovanna Brunasso, Alexandra Maria, and Cesare Massone. "Paradoxical Psoriasis During IL-17 Blockage: Two Memorable Patients." Dermatology and Dermatitis 6, no. 2 (2021): 01–02. http://dx.doi.org/10.31579/2578-8949/080.

Full text

Abstract:

47 year-old man who suffered for plaque psoriasis since 2013 was previously treated with topicals, UVB photherapy, acitretin, methotrexate and adalimumab (Imraldi®) with scarce response. Brodalumab (IL-17 receptor chain A blocking antibody) at 210 mg sc day 0, week-1, week-2 and every 2 weeks was initiated (baseline PASI of 16) with fast improvement of psoriasis (PASI-90 at week 4) and new onset of erythema, pustules and pain in the palmoplantar area after each subcutaneous Brodalumab administration and progressive improvement after 5-8 days.

APA, Harvard, Vancouver, ISO, and other styles

4

McFeely, O., E. Pender, L. Victory, H. Almutlaq, and E. Storan. "Risankizumab‐induced paradoxical pustular psoriasis." Clinical and Experimental Dermatology 47, no. 3 (2021): 616–17. http://dx.doi.org/10.1111/ced.15006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Dogra, S., A. Bishnoi, T. Narang, and S. Handa. "Secukinumab-induced paradoxical pustular psoriasis." Clinical and Experimental Dermatology 44, no. 1 (2018): 72–73. http://dx.doi.org/10.1111/ced.13731.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Amine, Ennaciri Mohamed, Maachi Malak, El Hallabi-Kettani Chaimae, et al. "Paradoxical Plaque Psoriasis on Infliximab in a Patient with Behçet's Disease." Scholars Journal of Medical Case Reports 12, no. 12 (2024): 2056–60. https://doi.org/10.36347/sjmcr.2024.v12i12.013.

Full text

Abstract:

TNF inhibitors are used in a number of diseases, including Behçet's disease and particularly its ophthalmological manifestations in cases of resistance or progression under conventional systemic treatments, notably corticosteroids. These TNF inhibitors are not without side effects, some of which are paradoxical in that they manifest themselves in diseases classically treated by these agents, such as psoriasis. Our case report is about a 25-year-old Behçet patient who received infliximab for corticoresistant uveitis. His uveitis has subsided but he developed a diffuse psoriasiform eruption 21 m

APA, Harvard, Vancouver, ISO, and other styles

7

Klimko, Artsiom, Andrei Ovidiu Olteanu, Ioana Tieranu, et al. "Paradoxical Psoriasis Induced by Ustekinumab: A Comprehensive Review and Case Report." Medicina 60, no. 1 (2024): 106. http://dx.doi.org/10.3390/medicina60010106.

Full text

Abstract:

Ustekinumab (UST), a biologic agent targeting interleukin-12 and interleukin-23, is widely used in the management of psoriasis and Crohn’s disease. Despite its efficacy, there have been instances of paradoxical psoriasis induction or exacerbation in some patients during UST therapy. This paper offers a comprehensive review of reported cases of UST-induced paradoxical psoriasis, including a case from our clinic. We focus on a 39-year-old female patient with a history of long-standing Crohn’s disease who developed a psoriasiform rash, as confirmed by biopsy, while undergoing UST treatment. The p

APA, Harvard, Vancouver, ISO, and other styles

8

Vender, Reid, and Ronald Vender. "Paradoxical, Cupping-Induced Localized Psoriasis: A Koebner Phenomenon." Journal of Cutaneous Medicine and Surgery 19, no. 3 (2015): 320–22. http://dx.doi.org/10.2310/7750.2014.14109.

Full text

Abstract:

Background Cupping therapy is a traditional Chinese medicine used to heal psoriasis. The Koebner phenomenon is the occurrence of psoriatic lesions at the site of cutaneous injury. Objective To describe the first case of biopsy-proven cupping-induced localized psoriasis, an example of the Koebner phenomenon. Methods The histopathology of the lesions is described. A brief review of the literature regarding cupping therapy and its efficacy are discussed. Results A 45-year-old Asian male presented himself to the dermatology clinic for further treatment of his psoriasis. Four unusually circular pla

APA, Harvard, Vancouver, ISO, and other styles

9

Ürün, Yıldız Gürsel, Hande Yelgen, Mustafa Ürün, and Nuray Can. "Secukinumab-induced paradoxical palmoplantar pustular psoriasis." TURKDERM 56, no. 4 (2022): 197–99. http://dx.doi.org/10.4274/turkderm.galenos.2022.39591.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Shareef, Narin, Josephina Price, Leila Ferguson та Alya Abdul-Wahab. "O10 Cohort study of paradoxical psoriasis in an adolescent population receiving anti-tumour necrosis factor-α for inflammatory bowel disease in a large teaching hospital with specialist dermatology and paediatric gastroenterology services". British Journal of Dermatology 189, № 3 (2023): e43-e43. http://dx.doi.org/10.1093/bjd/ljad259.010.

Full text

Abstract:

Abstract Paradoxical psoriasis is well recognized in adults receiving anti-tumour necrosis factor-(TNF)-α therapy for inflammatory bowel disease (IBD) [Bucalo A, Rega F, Zangrilli A et al. Paradoxical psoriasis induced by anti-TNFα treatment: evaluation of disease-specific clinical genetic markers. Int J Mol Sci 2020; 21: 7873. https://doi.org/10.3390/ijms21217873]. Biologics are increasingly being initiated earlier in the treatment ladder for IBD in the paediatric population, who are also vulnerable to paradoxical psoriasis. This observational study aimed to describe the clinical features and

APA, Harvard, Vancouver, ISO, and other styles

11

Budair, Fatimah Mohammad, Haya A. AlHemli, Adel A. Zeidan, Abdullah Alshehri, Jumana Alratroot, and Manal Hasan. "The immunological implications of paradoxical reactions in rheumatoid arthritis and psoriasis treatment: A case report." Electronic Journal of General Medicine 21, no. 6 (2024): em610. http://dx.doi.org/10.29333/ejgm/15521.

Full text

Abstract:

Psoriasis and rheumatoid arthritis (RA) are common chronic diseases with distinctive histological and molecular features. However, there are similarities in their immunological pathogenesis, leading to the use of some similar systemic biological treatment. In 5% of patients using biological therapy such as the anti-tumor necrosis factor alpha (anti-TNF-α), a paradoxical reaction (i.e., the exacerbation or development of one disease while treating the other) may develop. We report a case of a 27-year-old female diagnosed with seropositive RA who developed paradoxical psoriasis (PP) after the us

APA, Harvard, Vancouver, ISO, and other styles

12

Carriero, Antonio, Ennio Lubrano, Valentina Picerno, Angela Anna Padula, and Salvatore D’Angelo. "Paradoxical psoriatic arthritis in a patient with psoriasis treated with guselkumab." Clinical and Experimental Dermatology 47, no. 4 (2022): 783–85. http://dx.doi.org/10.1111/ced.15061.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Al-Janabi, Ali, Paul Martin, Catherine Simpson, et al. "O05 Single-cell transcriptomic signature of paradoxical eczema in patients with psoriasis treated with biologics." British Journal of Dermatology 190, no. 6 (2024): e70-e70. http://dx.doi.org/10.1093/bjd/ljae105.005.

Full text

Abstract:

Abstract Introduction and aims Biologics targeting the tumour necrosis factor (TNF) and the interleukin (IL)-17/23 axis are highly effective treatments for psoriasis but can result in cutaneous adverse events. The pathogenesis of paradoxical eczema, an atopic dermatitis (AD) phenotype occurring after biologic initiation in people with psoriasis, is unknown. This study explored the systemic disease signature of paradoxical eczema. Methods We used single-cell RNA-Seq on peripheral blood mononuclear cells (PBMCs) from three patients with psoriasis with paradoxical eczema, and three matched, biolo

APA, Harvard, Vancouver, ISO, and other styles

14

Zhukov, Alexander S., Alexander V. Patrushev, Vladislav R. Khairutdinov, Alexey V. Samtsov, and Evgeniy V. Kryukov. "New aspects of the pathogenesis of psoriasis." Vestnik dermatologii i venerologii 98, no. 4 (2022): 31–40. http://dx.doi.org/10.25208/vdv1345.

Full text

Abstract:

Psoriasis is a chronic multi-factorial immune-mediated inflammatory disease of skin and joints. The variety of clinical forms of dermatosis is consistent with various pathogenetic features of the disease progress which have been significantly supplemented and reviewed recently. Knowledge of these mechanisms will improve and personalize the prescribed therapy. This study places the emphasis on modern ideas about the formation of T cell memory, the role of melanocytes and innate lymphoid cells. Development mechanisms of guttate and paradoxical psoriasis with important distinguishing charac

APA, Harvard, Vancouver, ISO, and other styles

15

Lee, Ho Yeol, Cheong Ha Woo, and Sik Haw. "Paradoxical Flare of Psoriasis after Ustekinumab Therapy." Annals of Dermatology 29, no. 6 (2017): 794. http://dx.doi.org/10.5021/ad.2017.29.6.794.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Kim, Dong Sung, Ki Dam Kim, Jae Young Heo, Yu Sung Choi, Moon Kyun Cho, and Soo young Kim. "A case of Atopic Eczema-like Paradoxical Eruption in a patient with Psoriasis Receiving Secukinumab." Journal of the Korean Society for Psoriasis 20, no. 1 (2023): 35–38. http://dx.doi.org/10.23203/psoriasis.2023.20.1.35.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Fernandes, Larissa Starling de A., Daniela Martinez, Omar Lupi, Ricardo Barbosa Lima, Carlos José Martins, and Antonio D'`Acri. "Paradoxical skin reaction with infliximab treatment." Medicina (Ribeirao Preto Online) 51, no. 1 (2018): 82–86. http://dx.doi.org/10.11606/issn.2176-7262.v51i1p82-86.

Full text

Abstract:

Considering the increased utilization of anti-TNF medications in the treatment of inflammatory and autoimmune diseases, dermatologists should be aware of the possible adverse skin reactions. We describe a case of inverted psoriasis due to the use of infliximab used in the treatment of inflammatory bowel disease.

APA, Harvard, Vancouver, ISO, and other styles

18

Abbruzzese, Anna, Vincenzo Venerito, Giuseppe Lopalco, Marco Fornaro, Maria Giannotta, and Florenzo Iannone. "Paradoxical Pustular Psoriasis in a Patient With Psoriatic Arthritis on Secukinumab Treatment." JCR: Journal of Clinical Rheumatology 26, no. 6 (2019): e208-e209. http://dx.doi.org/10.1097/rhu.0000000000001076.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Ismail, Rasimah. "A Case Series Exploring the Efficacy, Secondary Failure, Paradoxical Event & Relapse with Ustekinumab Therapy in Chronic Plaque Psoriasis." Medicine & Health 15, no. 2 (2020): 153–63. http://dx.doi.org/10.17576/mh.2020.1502.15.

Full text

Abstract:

Ustekinumab is an anti-IL12/23 biologic agent used for treatment of psoriasis with excellent efficacy. However, there are therapeutic obstacles such as secondary failure and paradoxical event. Disease relapse upon discontinuation of therapy is common. A case series was performed on patients with chronic plaque psoriasis who received ustekinumab between 2013 to 2018 at a tertiary referral centre. Demographics, clinical characteristics, duration of therapy, efficacy, treatment complications, rate and pattern of relapses were determined from the patients’ medical records. Out of 8 patients, 6 (75

APA, Harvard, Vancouver, ISO, and other styles

20

Urushikubo, Jun, Keisuke Kawasaki, Makoto Eizuka, et al. "Ustekinumab Improves Paradoxical Enteropathy Associated With Psoriasis Arthritis." Inflammatory Bowel Diseases 25, no. 10 (2019): e128-e129. http://dx.doi.org/10.1093/ibd/izz154.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Mas-Vidal, Albert, Pablo Coto-Segura, Cristina Galache-Osuna, and Jorge Santos-Juanes. "Psoriasis induced by cetuximab: A paradoxical adverse effect." Australasian Journal of Dermatology 52, no. 1 (2010): 56–58. http://dx.doi.org/10.1111/j.1440-0960.2010.00675.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Yiu, Z. Z. N., F. R. Ali, and C. E. M. Griffiths. "Paradoxical exacerbation of chronic plaque psoriasis by sorafenib." Clinical and Experimental Dermatology 41, no. 4 (2015): 407–9. http://dx.doi.org/10.1111/ced.12788.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Bucalo, Agostino, Federica Rega, Arianna Zangrilli та ін. "Paradoxical Psoriasis Induced by Anti-TNFα Treatment: Evaluation of Disease-Specific Clinical and Genetic Markers". International Journal of Molecular Sciences 21, № 21 (2020): 7873. http://dx.doi.org/10.3390/ijms21217873.

Full text

Abstract:

Paradoxical psoriasis (PP) may occur during treatment with anti-tumor necrosis factor-alpha (TNF-α) drugs in various chronic immune-mediated diseases, mainly inflammatory bowel diseases (IBD) and psoriasis. In this study, clinical and genetic characteristics of PP arising in IBD and psoriatic patients were investigated to identify disease-specific markers of the paradoxical effect. A total of 161 IBD and psoriatic patients treated with anti-TNF-α drugs were included in the study. Of these patients, 39 developed PP. All patients were characterized for the main clinical–pathologic characteristic

APA, Harvard, Vancouver, ISO, and other styles

24

Boch, Katharina, Detlef Zillikens, Ralf J. Ludwig, and Diamant Thaçi. "Paradoxical improvement of life quality in the COVID-19 era in psoriasis patients." PLOS ONE 17, no. 9 (2022): e0275293. http://dx.doi.org/10.1371/journal.pone.0275293.

Full text

Abstract:

Background Psoriasis is a chronic immune-mediated inflammatory disease. Beyond the physical dimensions, the disease has an extensive emotional and psychosocial effect on patients, influencing their quality of life, social life and interpersonal relationships. Thus patient-reported outcomes are a crucial instrument for the evaluation of disease burden. Navigating life in times of the COVID-19 pandemic is challenging, especially for persons suffering from chronic diseases. We here analyzed the impact of lockdown restrictions on psoriasis patients. Objective To compare the Dermatology Life Qualit

APA, Harvard, Vancouver, ISO, and other styles

25

Dhaifallah Alrakawi Alenizi. "Adalimumab induced psoriasis in a Crohn’s disease patient: a case report." Journal of the Pakistan Medical Association 74, no. 7 (2024): 1361–63. http://dx.doi.org/10.47391/jpma.9817.

Full text

Abstract:

Adalimumab is a human monoclonal antibody that selectively targets tumour necrosis factor-alpha (TNF- Alpha), a cytokine involved in the pathogenesis of various inflammatory and autoimmune disorders. Adalimumab has been approved worldwide for the treatment of several chronic immune-mediated diseases, including rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, and juvenile idiopathic arthritis. One of the adverse reactions caused by Adalimumab is psoriasis. This study reports the case of a 37-year-old male with palmoplantar psoria

APA, Harvard, Vancouver, ISO, and other styles

26

Čarija, Antoanela, Ivo Ivić, Daniela Marasović-Krstulović, and Neira Puizina-Ivić. "Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab: Table 1." Rheumatology 54, no. 11 (2015): 2114–16. http://dx.doi.org/10.1093/rheumatology/kev263.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Su, Peiqi, and Jiun Yit Pan. "Paradoxical flare of psoriasis, psoriatic spondyloarthritis, and psoriatic uveitis after switching from infliximab to secukinumab." Dermatologica Sinica 35, no. 2 (2017): 112–13. http://dx.doi.org/10.1016/j.dsi.2016.10.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Hernández, Vianca Andrea Ramírez. "Drug-induced Psoriasis. A Review of the Literature." South Asian Research Journal of Applied Medical Sciences 7, no. 01 (2025): 24–27. https://doi.org/10.36346/sarjams.2025.v07i01.004.

Full text

Abstract:

Psoriasis is a chronic inflammatory skin disease with a complex and multifactorial pathophysiology. Among the triggering factors, certain medications have been implicated as causing the appearance of new cases or exacerbations in previously diagnosed patients. This article reviews the latest evidence on medications associated with induced psoriasis, paradoxical eruptions, the pathophysiological mechanisms involved, and clinical implications. Strategies for its management and prevention are also discussed, highlighting the importance of pharmacovigilance in these patients.

APA, Harvard, Vancouver, ISO, and other styles

29

Zheng, Qiaoli, Yingjie Zhu, Hao Cheng, and Kejian Zhu. "Uveitis Occurring in a Patient with Psoriasis during Adalimumab Therapy." Indian Journal of Dermatology 67, no. 2 (2022): 207. http://dx.doi.org/10.4103/ijd.ijd_366_21.

Full text

Abstract:

Here we report a case of a 34-year-old patient with psoriasis who developed uveitis induced by adalimumab. After receiving two subcutaneous injections of adalimumab, the patient suffered from a sudden onset of ocular pain and blurred vision in her left eye, which was diagnosed with acute anterior uveitis. Adalimumab therapy was discontinued and the patient was hospitalised for the treatment of acute anterior uveitis with systemic corticosteroids. This paradoxical adverse event was alleviated after timely interventions and went into remission during a 6-month follow-up period. To the best of ou

APA, Harvard, Vancouver, ISO, and other styles

30

Umami, Helmina Robiyatul. "Pilihan Pengobatan Pada Pasien Psoriasis Dengan HIV: Sebuah Tinjauan Sistematik." Jurnal Sains dan Kesehatan 2, no. 1 (2023): 13–22. http://dx.doi.org/10.57151/jurnalsainsdankesehatan.v2i1.159.

Full text

Abstract:

Psoriasis is a disease related to the immunity, usually inherited genetically and is chronic and recurring. When patients with psoriasis are infected with the Human Immunodeficiency Virus (HIV), the theory is that there is a paradoxical relationship that affects the two diseases. HIV can be a trigger for psoriasis and psoriasis can appear as an early symptom of HIV infection. The successful treatment of Psoriasis with HIV positive must be done appropriately according to the patient's condition. Here we discuss several Psoriasis therapy options in HIV positive patients based on several case rep

APA, Harvard, Vancouver, ISO, and other styles

31

Umami, Helmina Robiyatul. "Pilihan Pengobatan pada Pasien Psoriasis dengan HIV: Sebuah Tinjauan Sistematik." Jurnal Sains dan Kesehatan 2, no. 1 (2023): 13–22. http://dx.doi.org/10.57151/jsika.v2i1.159.

Full text

Abstract:

Psoriasis is a disease related to the immunity, usually inherited genetically and is chronic and recurring. When patients with psoriasis are infected with the Human Immunodeficiency Virus (HIV), the theory is that there is a paradoxical relationship that affects the two diseases. HIV can be a trigger for psoriasis and psoriasis can appear as an early symptom of HIV infection. The successful treatment of Psoriasis with HIV positive must be done appropriately according to the patient's condition. Here we discuss several Psoriasis therapy options in HIV positive patients based on several case rep

APA, Harvard, Vancouver, ISO, and other styles

32

Mendes Roncada, Eduardo V., Victoria Romanini Brambilla, Beatriz Freitas Filitto, Mariana Pirajá Genta, and Marilda Ap M. Morgado de Abreu. "Atopic Dermatitis as a Paradoxical Effect of Secukinumab for the Treatment of Psoriasis." Case Reports in Dermatology 13, no. 2 (2021): 336–39. http://dx.doi.org/10.1159/000513467.

Full text

Abstract:

In the therapeutic arsenal to treat moderate to severe psoriasis, the new agents are secukinumab and ustekinumab, which are fully human monoclonal antibodies, directed against IL-17A and IL-12/23, respectively, which have been shown to be effective and safe in several studies. Their side effects are rare, and the most frequently reported side effects were infection, especially nasopharyngitis, headache, pruritus, high blood pressure, and low back pain. Unlike the side effects, the paradoxical reaction can be defined by the appearance or exacerbation of a pathological condition that usually res

APA, Harvard, Vancouver, ISO, and other styles

33

Uchida, Shusuke, Naoki Oiso, Yoriaki Komeda, Masatoshi Kudo, and Akira Kawada. "Paradoxical ulcerative colitis during treatment with secukinumab for psoriasis." European Journal of Dermatology 29, no. 4 (2019): 444–45. http://dx.doi.org/10.1684/ejd.2018.3391.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Bordel-Gómez, MT, J. Sánchez-Estella, O. Martínez-González, and MªE Cardeñoso-Álvarez. "Palmoplantar psoriasis: a paradoxical adverse reaction induced by adalimumab." Journal of the European Academy of Dermatology and Venereology 23, no. 4 (2009): 444–45. http://dx.doi.org/10.1111/j.1468-3083.2008.02898.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Suh, Hyun Yi, Ji Young Ahn, Mi Youn Park, and Jai Il Youn. "Exacerbation of infliximab-induced paradoxical psoriasis after ustekinumab therapy." Journal of Dermatology 45, no. 3 (2017): 332–33. http://dx.doi.org/10.1111/1346-8138.13803.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Megna, Matteo, Sonia Sofia Ocampo-Garza, Luca Potestio, et al. "New-Onset Psoriatic Arthritis under Biologics in Psoriasis Patients: An Increasing Challenge?" Biomedicines 9, no. 10 (2021): 1482. http://dx.doi.org/10.3390/biomedicines9101482.

Full text

Abstract:

Psoriasis and psoriatic arthritis (PsA) development is sustained by tumor necrosis factor (TNF)α, interleukin (IL)17, and IL23; hence, biologics targeting those cytokines represent useful therapeutic weapons for both conditions. Nevertheless, biologics strongly reduce PsA risk; several studies reported the possibility of new-onset PsA during biologic therapy for psoriasis. The aim of this 1-year prospective study is to evaluate the prevalence of paradoxical PsA in psoriasis patients under biologic therapy and review the existing literature. For each patient, age, sex, psoriasis duration, psori

APA, Harvard, Vancouver, ISO, and other styles

37

Brugnera Nunes de Mattos, Alexandra, Mariane Maria Cerneski, Sheila Reichert, and Cassia Nava Jaeger. "Use of Adalimumab, a TNF-Alpha Inhibitor, is Associated with Paradoxical Psoriasis: Two Clinical Case Reports." Brazilian Journal of Case Reports 3, no. 2 (2023): 12–15. http://dx.doi.org/10.52600/2763-583x.bjcr.2023.3.2.12-15.

Full text

Abstract:

The use of tumor necrosis factor (anti-TNF) antagonists has become a practice applied in the treatment of various inflammatory diseases, such as psoriasis. However, the use of Anti-TNF can, paradoxically, trigger side effects as a form of psoriasiform or worsening of pre-existing symptoms, in patients with or without previously diagnosed psoriasis. In view of this, two case reports were described. First, we described a 21-year-old female patient who used adalimumab for four months due to extensive suppurative hidradenitis. In the second case, we related a 32-year-old male patient diagnosed wit

APA, Harvard, Vancouver, ISO, and other styles

38

Ferraresso, María Guillermina, María Luz Bollea Garlatti, Lourdes María Perez-Chada, Mariana Soledad Martin, and Luis Daniel Mazzuoccolo. "Certolizumab-Induced Paradoxical Psoriatic Alopecia." Journal of Psoriasis and Psoriatic Arthritis 5, no. 3 (2020): 86–92. http://dx.doi.org/10.1177/2475530320928625.

Full text

Abstract:

Introduction: Biologic drugs have revolutionized the treatment of chronic inflammatory immunologic diseases. However, their use is associated with adverse reactions, including paradoxical adverse events. Tumor necrosis factor (TNF)–associated psoriatic alopecia (TiAPA) is a paradoxical adverse event that has been rarely reported in the literature. Only 1 case secondary to certolizumab has been recently described. Case Presentation: We described a case of scalp alopecia secondary to certolizumab in a 27-year old female patient with Crohn disease. The skin biopsy showed psoriasiform changes and

APA, Harvard, Vancouver, ISO, and other styles

39

Hardman-Smart, J., S. Solanky, O. Munir, et al. "056 Dissecting the pathogenesis of anti-TNF-induced paradoxical psoriasis." Journal of Investigative Dermatology 141, no. 10 (2021): S158. http://dx.doi.org/10.1016/j.jid.2021.08.058.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Xia, Ping, Yan-Hong Li, Zhong Liu, et al. "Recalcitrant paradoxical pustular psoriasis induced by infliximab: Two case reports." World Journal of Clinical Cases 9, no. 15 (2021): 3655–61. http://dx.doi.org/10.12998/wjcc.v9.i15.3655.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Nguyen, Douglas, Nneka Comfere, William Sandborn, Edward Loftus, and David Bruining. "Anti-TNF Alpha Drug Induced Pustular Psoriasis - A Paradoxical Reaction." American Journal of Gastroenterology 104 (October 2009): S354. http://dx.doi.org/10.14309/00000434-200910003-00961.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Gimeno-Castillo, Javier, Pau Rosés-Gibert, AidaMenéndez Parrón, FranciscoJ de la Torre Gomar, and ZuriñeMartínez de Lagrán-Álvarez de Arcaya. "Paradoxical SAPHO syndrome after etanercept in a patient with psoriasis." Indian Journal of Dermatology 67, no. 6 (2022): 822. http://dx.doi.org/10.4103/ijd.ijd_353_22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Shahid, Tamoor, Saad Bin Jamil, Harish Guddati, Kamran Zahid, and Hilary Hertan. "Anti-TNF Alpha-Induced Psoriasis: A Rare Paradoxical Side Effect." American Journal of Gastroenterology 112 (October 2017): S1110—S1111. http://dx.doi.org/10.14309/00000434-201710001-02017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Croitoru, D. O., L. Eder, S. Cachetaux, et al. "395 Defining Paradoxical Psoriasis and Deep Tissue Immune Cell Profiling." Journal of Investigative Dermatology 142, no. 12 (2022): S248. http://dx.doi.org/10.1016/j.jid.2022.09.408.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Zhou, Qianqian, Shengru Zhou, Huizi Xiong, et al. "A Case of Paradoxical Reactions to Biologic Therapy for Psoriasis." Clinical, Cosmetic and Investigational Dermatology Volume 16 (June 2023): 1493–97. http://dx.doi.org/10.2147/ccid.s412520.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Fauny, Marine, David Moulin, Ferdinando D'Amico, et al. "Paradoxical gastrointestinal effects of interleukin-17 blockers." Annals of the Rheumatic Diseases 79, no. 9 (2020): 1132–38. http://dx.doi.org/10.1136/annrheumdis-2020-217927.

Full text

Abstract:

Secukinumab, ixekizumab and brodalumab are monoclonal antibody therapies that inhibit interleukin (IL)-17 activity and are widely used for the treatment of psoriasis, psoriatic arthritis and ankylosing spondylitis. The promising efficacy results in dermatology and rheumatology prompted the evaluation of these drugs in Crohn’s disease and ulcerative colitis, but the onset of paradoxical events (disease exacerbation after treatment with a theoretically curative drug) prevented their approval in patients with inflammatory bowel diseases (IBDs). To date, the pathophysiological mechanisms underlyin

APA, Harvard, Vancouver, ISO, and other styles

47

Cottone, Mario, Chiara Sapienza, Fabio Salvatore Macaluso, and Marco Cannizzaro. "Psoriasis and Inflammatory Bowel Disease." Digestive Diseases 37, no. 6 (2019): 451–57. http://dx.doi.org/10.1159/000500116.

Full text

Abstract:

Background: Inflammatory bowel disease (IBD) and psoriasis (PS) are associated conditions. The reason for this association lies in the sharing of predisposition genes and common immunological mechanisms. Summary: This review will focus on the interplay between IBD and PS, with details on prevalence and phenotype of PS in IBD, genetics, pathogenetic pathways, and therapy. Key Messages: Microbiome seems relevant in both conditions: a reduction of beneficial bacteria has been observed. IBD and PS have in common some comorbidities like cardiovascular disease, similar risk of cancer and psychiatric

APA, Harvard, Vancouver, ISO, and other styles

48

Zangrilli, Arianna, Mauro Bavetta, Sara Mazzilli, Virginia Garofalo, and Luca Bianchi. "Paradoxical case effects of psoriasis following adalimumab therapy: A case series." Dermatologic Therapy 31, no. 6 (2018): e12729. http://dx.doi.org/10.1111/dth.12729.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Vidal, D., S. Ros, and D. Reina. "Paradoxical Arthritis Due to Ixekizumab in a Patient With Plaque Psoriasis." Actas Dermo-Sifiliográficas (English Edition) 110, no. 3 (2019): 255–56. http://dx.doi.org/10.1016/j.adengl.2017.12.025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Bataille, P., A. Masson, M. Vignon-Pennamen, J. Bouaziz, and J. Gornet. "Possible Paradoxical Photosensitive Psoriasis Induced by Tumour Necrosis Factor-alpha Inhibitors." Acta Dermato Venereologica 99, no. 13 (2019): 1293–94. http://dx.doi.org/10.2340/00015555-3330.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!